Table 7.

Lipid and blood glucose profiles

Variable		n	Baseline	ΔWeek 12	ΔWeek 24
TC (mg/dl)	Placebo	33	240 ± 38	−6 ± 18	−12 ± 30
	Active	28	233 ± 37	5 ± 22	2 ± 17
	p		0.460	0.043*	0.026*
HDL-C (mg/dl)	Placebo	33	72 ± 16	−4 ± 6	−4 ± 6
	Active	28	76 ± 21	−3 ± 12	−1 ± 6
	p		0.423	0.666	0.074
LDL-C (mg/dl)	Placebo	33	147 ± 32	−4 ± 17	−8 ± 26
	Active	28	139 ± 33	5 ± 14	1 ± 14
	p		0.343	0.029*	0.093
TG (mg/dl)	Placebo	33	116 ± 55	8 ± 58	−2 ± 48
	Active	28	106 ± 70	10 ± 39	6 ± 50
	p		0.538	0.883	0.535
BG (mg/dl)	Placebo	33	95 ± 10	0 ± 8	1 ± 6
	Active	28	96 ± 10	−1 ± 7	0 ± 5
	p		0.667	0.639	0.765
HbA1c (%)	Placebo	33	5.6 ± 0.4	0.0 ± 0.1	−0.1 ± 0.1
	Active	28	5.4 ± 0.3	−0.1 ± 0.2	−0.1 ± 0.1
	p		0.100	0.413	0.967

Values are shown as mean ± SD. ΔWeek 12 and 24: change in value from baseline to week 12 and 24, respectively. Student’s t test was performed. *p<0.05 vs placebo group. TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; BG, blood glucose; HbA1c, hemoglobin A1c.